Deucravacitinib: A Year in Review
As deucravacitinib surpasses its 1-year milestone since approval, clinicians continue to monitor its real-world performance among patients.
Key Takeaways for the Management of PP
Experts discuss key takeaways for providers in the management of plaque psoriasis (PP).
Positioning Aryl Hydrocarbon Receptor Agonists in PP Treatment Regimens
Tj Chao, MPAS, and Lauren Miller, MPAS, discuss possible treatment algorithms when using tapinarof for plaque psoriasis (PP) patients.
Identifying the Remittive Effect in PP Patients
Lauren Miller, MPAS, and Tj Chao, MPAS, discuss the clinical importance of the remittive effect in plaque psoriasis (PP) patients.
Long-Term Efficacy and Safety Data on PP Treatments
Experts discuss recent studies of novel treatments for plaque psoriasis (PP) and the importance of long-term data.
Tapinarof Selectivity and Mechanism of Action for PP Treatment
Tj Chao, MPAS, and Lauren Miller, MPAS, discuss tapinarof as a treatment for plaque psoriasis (PP).
Aryl Hydrocarbon Receptor Treatments for PP
Lauren Miller, MPAS, and Tj Chao, MPAS, discuss new treatments for plaque psoriasis (PP) and their mechanisms of action.
Topical Therapy Options for PP
Experts discuss the landscape of topical drugs for plaque psoriasis (PP) and key factors in treatment options.
PP Treatment Efficacy
Tj Chao, MPAS, and Lauren Miller, MPAS, highlight treatment efficacy considerations for plaque psoriasis (PP).
Drug Class Considerations for Patients With PP
Lauren Miller, MPAS, and Tj Chao, MPAS, discuss how patient goals and education can inform next steps of treatment for plaque psoriasis (PP).
PP Treatment Selection: Best Practices
Experts offer insights on treatment selection and patient education for plaque psoriasis (PP).
Caring for Pediatric Patients With PP
Lauren Miller, MPAS, and Tj Chao, MPAS, offer considerations for treating pediatric patients with plaque psoriasis (PP).
Treatment Options for Pregnant People With PP
Experts discuss plaque psoriasis (PP) treatment options for people who are or may become pregnant.
Impact of PP Comorbidities
Tj Chao, MPAS, and Lauren Miller, MPAS, highlight comorbidities that caregivers should consider when treating patients with plaque psoriasis (PP).
Factors to Consider when Treating PP
Lauren Miller, MPAS, and Tj Chao, MPAS, discuss key factors to consider for plaque psoriasis (PP) treatment.
The Role of Physician Assistants in PP Management
Experts discuss the role and importance of physician assistants in the treatment and care of plaque psoriasis (PP).
Overview of PP
Tj Chao, MPAS, and Lauren Miller, MPAS, discuss the symptoms of plaque psoriasis (PP) and why it may be difficult to diagnose.
